Annual General Meeting for FY2019

The Company’s Annual General Meeting (“AGM”) is being convened, and will be held, by electronic means pursuant to the COVID-19 (Temporary Measures) (Alternative Arrangements for Meetings for Companies, Variable Capital Companies, Business Trusts, Unit Trusts and Debenture Holders) Order 2020. Printed copies of the Notice of AGM, Audited Financial Statements for the financial year ended 31 December 2019 and Proxy Form will be sent by ordinary post to members.

Alternative arrangements relating to, among others, attendance, submission of questions in advance and/voting by proxy at the AGM are set out in the Company’s Notice of AGM. A member will not be able to attend the AGM in person. A member (whether individual or corporate) must appoint the Chairman of the AGM as his/her/its proxy to attend, speak and vote on his/her/its behalf at the AGM if such member wishes to exercise his/her/its voting rights at the AGM. Where a member (whether individual or corporate) appoints the Chairman of the AGM as his/her/its proxy, he/she/it must give specific instructions as to voting, or abstentions from voting, in respect of a resolution in the form of proxy, failing which the appointment of the Chairman of the AGM as proxy for that resolution will be treated as invalid.

Completed proxy forms must be submitted via email to the Company at legal@tessatherapeutics.com by 6.00 p.m. on 2nd July 2020.

Shareholders who would like to attend the AGM should pre-register via the Pre-Registration Form by 6.00 p.m. on 2nd July 2020. Following verification, authenticated shareholders will receive an email by 6.00 p.m. on 3rd July 2020 containing the details to access the live webcast and live audio feed of the AGM proceedings.

Notice of AGM
Download PDF

Proxy Form
Download PDF

Pre-Registration Form
Register here